May 28, 2001 |
Question: So there's a bunch of new cholesterol guidelines. Why should I care this time? Answer: The guidelines, issued recently by the National Heart, Lung and Blood Institute, are more aggressive than earlier ones. The government wants to treat more people, and treat them sooner to prevent heart disease and its related deaths (and costs). So if you didn't qualify for cholesterol-lowering treatment under the old recommendations, you may qualify now.
July 20, 2010 |
Add sepsis to your list of post-surgery worries. Or, if you're so inclined, to your list of worries in general. First, we'll look at the hospital picture. Researchers at Methodist Hospital, Weill Cornell Medical College, set out to document the incidence, mortality rate and risk factors for sepsis and septic shock after general surgery. And what they found wasn't pretty. Using data from 363,897 patients, they established that sepsis, a life-threatening blood infection, occurred in 2.3% of those patients and that septic shock, dangerously low blood pressure from said blood infection, occurred in 1.6%.
July 15, 2010 |
David Axene was flat on his back in a hospital bed with a swollen left leg. His kidneys had shut down. His blood pressure had plunged. Doctors pumped him with potent antibiotics to stave off a deadly infection. Yet there he was sifting through spreadsheets on his laptop, cradling his cellphone to his ear, waving off doctors to finish another conference call. California's top insurance watchdogs had hired Axene to scour Anthem Blue Cross' files for any flaw in the voluminous paperwork that accompanied its rate hikes of up to 39%. Anthem's plan to impose higher premiums March 1 had outraged consumers and politicians alike.
October 7, 2002 |
The easiest way to assess your heart disease risk may be to measure your waist. A study of more than 9,000 white men and women found that the thickness of a person's midsection is more closely associated with other risk factors, such as cholesterol and glucose levels and blood pressure, than body mass index, or BMI. BMI, which is based on height and weight, has been used since the 1980s to estimate the risk of obesity-related diseases.
February 3, 2011 |
Heart disease, heart health, cardiovascular risk factors ... the terms will appear in infinite variety this month, as will the color red. If you don't know why (Valentine's Day is only part of the reason), you haven't been paying attention: February is American Heart Month and the American Heart Assn. has ramped up its Go Red for Women campaign. If you have been paying attention, good -- we can move on to more specific information. The point of the dual observances, of course, is to underscore the fact that cardiovascular disease claims about 2,200 lives a day in the United States.
January 19, 2011 |
Statin drugs are used by millions of Americans to lower cholesterol, but should they be so widespread? A new study suggests maybe not. British researchers say there's little evidence that statin drugs prevent heart disease in people who are at low risk for the disease. The study involved a review of data on 34,272 patients at low risk for heart attack and stroke between 1994 and 2006. It was conducted by the Cochrane Collaboration, an international organization that reviews medical research.
August 9, 2010 |
Signs of heart disease -- generally thought to be a disease of middle age -- can be seen even in children, cardiologists now know. But risk factors in children and young adults run the risk of being undetected and untreated, largely because of confusion as to who among the young should get screened, and when. One of the most efficient ways to screen for heart-disease risk is via tests for levels of low-density lipoprotein (LDL, or "bad") cholesterol. And yet often that screen doesn't get done.
April 1, 2010 |
Men at an above-normal risk of prostate cancer may be able to reduce their risk of developing the disease by taking a drug already on the market. In research reported Wednesday, the drug dutasteride, currently used to shrink enlarged prostates, was found to reduce the risk of prostate cancer by about a quarter in high-risk men. The medication, sold under the brand name Avodart, apparently caused small tumors to stop growing or even to shrink, researchers...